Gen AI based Drug Discovery Platform
Developing novel antimicrobial drugs, by a rational approach taking into account the mechanisms of Antimicrobial drug Resistance by targeting the pathways or proteins. Generative AI models are developed taking into account comprehensive and unbiased data sets followed by in vitro and in vivo validation
Developing novel antimicrobial drugs, by a rational approach taking into account the mechanisms of Antimicrobial drug Resistance by targeting the pathways or proteins. Generative AI models are developed taking into account comprehensive and unbiased data sets followed by in vitro and in vivo validation
Gen AI-based
Drug Discovery
Platform
SC004+SCAB1
Oral formulation
(Fixed dose combination)
Developing novel antimicrobial drugs, by a rational approach taking into account the mechanisms of Antimicrobial drug Resistance by targeting the pathways or proteins. Generative AI models are developed taking into account comprehensive and unbiased data sets followed by in vitro validation.
The AMR Lab is dedicated to advancing our understanding of AMR through cutting-edge research and innovation. Utilizing state-of-the-art technologies such as whole-genome sequencing, transcriptomics, and AI/ML analytics, the lab is focused on deciphering the mechanisms inorder to mitigate the impact of Antimicrobial resistance and support global healthcare community.
